Fig. 8: In vivo vascular fluorescence imaging in mice following intravenous ICG or JAM317 administration. | npj Imaging

Fig. 8: In vivo vascular fluorescence imaging in mice following intravenous ICG or JAM317 administration.

From: Low molecular weight 4,4’-quinocyanines for in vivo NIR-II fluorescence imaging

Fig. 8: In vivo vascular fluorescence imaging in mice following intravenous ICG or JAM317 administration.

In vivo fluorescence imaging of mouse vasculature following intravenous injection of ICG (A–C) or JAM317 (D–G). ICG imaged in the NIR-I window A, NIR-II with a 1000 nm long-pass filter B, and NIR-II with a 1250 nm long-pass filter C demonstrates progressively reduced signal and spatial resolution at longer wavelengths. JAM317 (40 nmol, eggPC liposomes) imaged with 1000 nm D and 1250 nm E long-pass filters shows enhanced vessel contrast and improved visualization of fine vascular structures at longer wavelengths. Contrast-enhanced images F, G were generated using ImageJ’s CLAHE plugin, with inverted images providing clear delineation of vascular networks. A supplemental video shows real-time biodistribution and vascular illumination following JAM317 injection.

Back to article page